A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
Active, not recruiting · NCT04929379 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Active, not recruiting | Phase 2 | 2026-02-06 | NCT04929379 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alessandro Doria | 2 |
| University of Michigan | 394 |
| University of Minnesota | 344 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brehm Center for Diabetes Research / University of Michigan | Ann Arbor | United States | 1 |
| Joslin Diabetes Center | Boston | United States | 37 |
| Lahey Hospital and Medical Center | Burlington | United States | 63 |
| SUNY Upstate Medical University | Syracuse | United States | 68 |